Chrysin Attenuates Myocardial Cell Apoptosis in Mice

Area of Science:

• Cardiovascular Biology
• Natural Product Chemistry
• Molecular Medicine

Background:

• Myocardial infarction (MI) involves heart muscle necrosis due to ischemia and hypoxia.
• Current treatments for MI have limitations, necessitating novel therapeutic strategies.
• Chrysin, a flavonoid from natural sources, possesses known beneficial bioactivities.

Purpose of the Study:

• To investigate the cardioprotective mechanisms of chrysin in myocardial infarction models.
• To elucidate the molecular pathways modulated by chrysin in the context of cardiac injury.
• To assess the potential of chrysin as a therapeutic agent for myocardial infarction.

Main Methods:

• Myocardial infarction (MI) and ischemia-reperfusion models were employed.
• Molecular analyses included Western blotting, immunofluorescence, and qPCR.
• Autodocking simulations were utilized to explore molecular interactions.

Main Results:

• Chrysin reduced cardiomyocyte apoptosis by modulating the Bax/Bcl-2 ratio and inhibiting caspase-3 activation via PPAR-γ.
• Chrysin mitigated cardiac fibrosis by downregulating TGF-β1, collagen I, and α-SMA.
• Chrysin improved cardiac function and reduced infarct size, linked to PPAR-γ, SIRT3, and β-catenin pathway activation.

Conclusions:

• Chrysin demonstrates significant cardioprotective effects in preclinical MI models.
• The mechanisms involve anti-apoptotic, anti-fibrotic, and signaling pathway modulation.
• Chrysin shows promise as a novel therapeutic candidate for myocardial infarction treatment.